APARITO LIMITED

Active Wrexham

Research and experimental development on biotechnology

28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

APARITO LIMITED

Research and experimental development on biotechnology

Founded 29 Oct 2014 Active Wrexham, Wales 28 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 17 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 10 Nov 2025 Next due 11 Nov 2026 6 months remaining
Net assets £15M £14M 2024 year on year
Total assets £20M £19M 2024 year on year
Total Liabilities £5M £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Ty Dewi Sant Rhosddu Road Wrexham LL11 1NF Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for APARITO LIMITED (09285366), an active life sciences and medical technology company based in Wrexham, Wales. Incorporated 29 Oct 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£9.07M

Increased by £8.14M (+882%)

Net Assets

£15.03M

Increased by £14.44M (+2484%)

Total Liabilities

£4.92M

Increased by £4.30M (+693%)

Turnover

N/A

Employees

28

Debt Ratio

25%

Decreased by 27 (-52%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 2

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2015Seed, Unknown/Other
Investor 2Apr 2015Seed
Investor 3Mar 2019Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 63,619 Shares £17051.87m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Dec 202316,887£17050.36m£1.01m
5 Nov 2020918£50k£54.47
17 Oct 2020918£50k£54.47
17 Sept 20206,120£333k£54.47
9 Apr 2019964£30k£31.11

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Eli Lilly And Company
NaN%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Eli Lilly And Company

United States Of America

Active
Notified 24 May 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Dr Elin Haf Davies

Ceased 24 May 2024

Ceased

Group Structure

Group Structure

APARITO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Nov 2025Confirmation StatementConfirmation statement made on 28 Oct 2025 with no updates
17 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
3 Sept 2025OfficersChange to director Kristina Mignon Wright on 1 Sept 2025
13 Aug 2025OfficersAppointment of Kristina Mignon Wright as director on 8 Aug 2025
13 Aug 2025OfficersTermination of Yuya Nonaka as director on 8 Aug 2025
10 Nov 2025 Confirmation Statement

Confirmation statement made on 28 Oct 2025 with no updates

17 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

3 Sept 2025 Officers

Change to director Kristina Mignon Wright on 1 Sept 2025

13 Aug 2025 Officers

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

13 Aug 2025 Officers

Termination of Yuya Nonaka as director on 8 Aug 2025

Recent Activity

Latest Activity

Confirmation statement made on 28 Oct 2025 with no updates

6 months ago on 10 Nov 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 17 Sept 2025

Change to director Kristina Mignon Wright on 1 Sept 2025

8 months ago on 3 Sept 2025

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

8 months ago on 13 Aug 2025

Termination of Yuya Nonaka as director on 8 Aug 2025

8 months ago on 13 Aug 2025